Stoke Therapeutics names Ian Smith as permanent CEO
Go back to Stoke Therapeutics names Ian Smith as permanent CEO| (NASDAQ: STOK) | Delayed: 31.38 -1.45 (4.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.83 | 52 Week High | $ | |||
| Open | $32.83 | 52 Week Low | $ | |||
| Day High | $33.02 | P/E | N/A | |||
| Day Low | $30.07 | EPS | $ | |||
| Volume | 614,856 | |||||

